UTILIZATION OF SMOKING CESSATION PRODUCTS IN THE MISSISSIPPI MEDICAID FEE-FOR-SERVICE POPULATION
Author(s)
Shah R1, Mahabaleshwarkar R1, Null KD1, Hardwick SP2, Clark JP2
1University of Mississippi, University, MS, USA, 2Mississippi Division of Medicaid, Jackson, MS, USA
OBJECTIVES: This study assessed the utilization and treatment patterns of smoking cessation products in the Mississippi Medicaid Fee-For-Service (FFS) population in order to enhance and promote smoking cessation efforts in this population. Finally, the impact of inclusion of these products on the monthly prescription cap was also evaluated. METHODS: Mississippi Medicaid FFS prescription claims data for the years 2012-2013 were analyzed. Only beneficiaries enrolled continuously in Medicaid were considered in the analysis. Dual eligibles were excluded from the study. Drugs dispensed were identified using National Drug Codes. Utilization as well as medication use patterns of nicotine replacement therapies, bupropion hydrochloride, and varenicline was studied. All results were reported by age, gender, race, pregnancy status, and Medicaid plan ID. Distribution of beneficiaries in terms of number of fills for each drug was determined in order to assess new therapy starts and duration of therapy. RESULTS:
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PRS64
Topic
Health Service Delivery & Process of Care, Organizational Practices
Topic Subcategory
Academic & Educational, Prescribing Behavior, Treatment Patterns and Guidelines
Disease
Respiratory-Related Disorders